Symetis grows and invests on its Ecublens site – article from AGEFI
Symetis grows and invests on its Ecublens site – [...]
Need a new search
If you didn't find what you were looking for, try a new search!
Symetis launches its IPO on Euronext Paris
Symetis launches its IPO on Euronext Paris Symetis [...]
Symetis launches €55M IPO for artificial heart valves
Symetis launches €55M IPO for artificial heart valves [...]
Symetis and Boston Scientific reach USD 435 million purchase agreement
Symetis and Boston Scientific reach USD 435 million purchase [...]
Symetis announces intention to float on SIX Swiss Exchange
Symetis announces intention to float on SIX Swiss Exchange [...]
Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo™, and Launches Product With First Commercial Implantations
Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic [...]
Symetis Announces a Symbolic Milestone – the 1000th Patient Implanted with ACURATE TA
Symetis Announces a Symbolic Milestone – the 1000th Patient [...]
Endeavour Vision accelerates investments in Switzerland and the US – an interview with AGEFI
Endeavour Vision accelerates investments in Switzerland and the US [...]
Endeavour Vision aims to be among the world leaders – an interview with AGEFI
Endeavour Vision aims to be among the world leaders [...]
How Endeavour became a reference in medtech – an interview with Bilan
How Endeavour became a reference in medtech – an [...]